SYRE

Spyre Therapeutics Inc

Jun 23 • 04:00PM ET

97.05

-3.27 -3.26 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: VTI IWM XBI VXF IBB SCHA IWO VTWO IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	10.85%	Shs Outstand	78.84M	Perf Week	16.12%
Market Cap	8.43B	Forward P/E	-	EPS next Y	-3.21	Insider Trans	-34.67%	Shs Float	77.42M	Perf Month	30.58%
Enterprise Value	7.84B	PEG	-	EPS next Q	-0.76	Inst Own	87.15%	Short Float	16.31%	Perf Quarter	126.96%
Income	-168.74M	P/S	-	EPS this Y	-52.10%	Inst Trans	1.14%	Short Ratio	10.24	Perf Half Y	189.96%
Sales	0.00M	P/B	14.86	EPS next Y	-6.57%	ROA	-25.30%	Short Interest	12.63M	Perf YTD	196.25%
Book/sh	6.53	P/C	11.37	EPS next 5Y	-23.61%	ROE	-29.26%	52W High	101.71 -4.58%	Perf Year	561.10%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	14.00 593.21%	Perf 3Y	870.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.90% 5.88%	Perf 5Y	-40.55%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	5.28	Perf 10Y	-19.12%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	72.07	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	22.66%	Beta	2.98	Target Price	100.47
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	30.06%	Rel Volume	2.12	Prev Close	100.32
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	132.70%	Avg Volume	1.23M	Price	97.05
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	2,610,243	Change	-3.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)